您当前的位置：
首页 >
文章列表页 >
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
更新时间：2026-01-27

    • Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer

    • China Oncology   Vol. 31, Issue 3, Pages: 221-226(2021)

    • DOI：10.19401/j.cnki.1007-3639.2021.03.009    

      CLC： R737.9

    • Published Online：01 April 2021，

      Published：01 April 2021

    移动端阅览

  • 胡喜娥, 杨振宇, 薛景毅, et al. Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer[J]. China Oncology, 2021, 31(3): 221-226. DOI： 10.19401/j.cnki.1007-3639.2021.03.009.

  •  
  •  
icon
试读结束，您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束，您可以通过登录账户，到个人中心，购买VIP会员阅读全文。
已是VIP会员？
去登录 >

0

Views

2178

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

The value of single-cell sequencing in oral squamous cell carcinoma research
Research progress and clinical significance of breast cancer heterogeneity
Selective elimination of axillary surgery staging after neoadjuvant chemotherapy for HER2 positive and triple-negative breast cancer
Advances in understanding the correlation between lymph node metastasis and immune regulation in breast cancer through spatiotemporal transcriptomic analysis
TIPE regulates glucometabolic reprogramming by modulating LDHA expression in triple-negative breast cancer

Related Author

Xiaocong WANG
Ming LI
蒋梦怡
陆言巧
王红霞
石志强
邱鹏飞
刘雁冰

Related Institution

School of Stomatology, Hunan University of Chinese Medicine
Changsha Stemmatological Hospital Special Clinic Center
南京医科大学附属上海一院临床医学院肿瘤科
上海交通大学附属胸科医院心内科
山东第一医科大学（山东省医学科学院）
0